← Back to toolboxDrugs & mechanisms

Antibody–drug conjugate

Antibody–drug conjugate · ADC

A treatment linking an antibody to a drug payload through a linker.

How to read it

Read the target, linker, payload and clinical evidence separately.

A common pitfall

ADCs sharing a target need not share efficacy or toxicity.

Read it in context

Genmab’s Rina-S: Revisiting a $1.8 Billion Acquisition →

Source

Read the primary source ↗

Explanations by Before the Conclusion · October 29, 2026